Global Viral Vectors and Plasmid DNA Manufacturing Market Overview And Scope:
Global Viral Vectors and Plasmid DNA Manufacturing Market Size was estimated at USD 719.33 million in 2022 and is projected to reach USD 1959.7 million by 2028, exhibiting a CAGR of 18.18% during the forecast period.
The Global Viral Vectors and Plasmid DNA Manufacturing Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Viral Vectors and Plasmid DNA Manufacturing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory
Global Viral Vectors and Plasmid DNA Manufacturing Market Segmentation
By Type, Viral Vectors and Plasmid DNA Manufacturing market has been segmented into:Plasmid DNA
Viral Vectors
By Application, Viral Vectors and Plasmid DNA Manufacturing market has been segmented into:
Cancers
Inherited Disorders
Viral Infections
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Viral Vectors and Plasmid DNA Manufacturing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Viral Vectors and Plasmid DNA Manufacturing market.
Top Key Players Covered in Viral Vectors and Plasmid DNA Manufacturing market are:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Objective to buy this Report:
1. Viral Vectors and Plasmid DNA Manufacturing analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Viral Vectors and Plasmid DNA Manufacturing market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Viral Vectors and Plasmid DNA Manufacturing Market by Type
5.1 Viral Vectors and Plasmid DNA Manufacturing Market Overview Snapshot and Growth Engine
5.2 Viral Vectors and Plasmid DNA Manufacturing Market Overview
5.3 Plasmid DNA
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Plasmid DNA: Geographic Segmentation
5.4 Viral Vectors
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Viral Vectors: Geographic Segmentation
Chapter 6: Viral Vectors and Plasmid DNA Manufacturing Market by Application
6.1 Viral Vectors and Plasmid DNA Manufacturing Market Overview Snapshot and Growth Engine
6.2 Viral Vectors and Plasmid DNA Manufacturing Market Overview
6.3 Cancers
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Cancers: Geographic Segmentation
6.4 Inherited Disorders
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Inherited Disorders: Geographic Segmentation
6.5 Viral Infections
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Viral Infections: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Viral Vectors and Plasmid DNA Manufacturing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Viral Vectors and Plasmid DNA Manufacturing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BIORELIANCE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 COBRA BIOLOGICS
7.4 OXFORD BIOMEDICA
7.5 UNIQURE
7.6 FINVECTOR
7.7 MOLMED
7.8 MASSBIOLOGICS
7.9 RICHTER-HELM
7.10 FUJIFILM DIOSYNTH BIOTECHNOLOGIES
7.11 LONZA
7.12 ALDEVRON
7.13 EUROGENTEC
7.14 CELL AND GENE THERAPY CATAPULT
7.15 BIOVIAN
7.16 THERMO FISHER SCIENTIFIC (BRAMMER BIO)
7.17 VGXI
7.18 PLASMIDFACTORY
Chapter 8: Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Plasmid DNA
8.2.2 Viral Vectors
8.3 Historic and Forecasted Market Size By Application
8.3.1 Cancers
8.3.2 Inherited Disorders
8.3.3 Viral Infections
8.3.4 Others
Chapter 9: North America Viral Vectors and Plasmid DNA Manufacturing Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Plasmid DNA
9.4.2 Viral Vectors
9.5 Historic and Forecasted Market Size By Application
9.5.1 Cancers
9.5.2 Inherited Disorders
9.5.3 Viral Infections
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Viral Vectors and Plasmid DNA Manufacturing Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Plasmid DNA
10.4.2 Viral Vectors
10.5 Historic and Forecasted Market Size By Application
10.5.1 Cancers
10.5.2 Inherited Disorders
10.5.3 Viral Infections
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Viral Vectors and Plasmid DNA Manufacturing Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Plasmid DNA
11.4.2 Viral Vectors
11.5 Historic and Forecasted Market Size By Application
11.5.1 Cancers
11.5.2 Inherited Disorders
11.5.3 Viral Infections
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Plasmid DNA
12.4.2 Viral Vectors
12.5 Historic and Forecasted Market Size By Application
12.5.1 Cancers
12.5.2 Inherited Disorders
12.5.3 Viral Infections
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Plasmid DNA
13.4.2 Viral Vectors
13.5 Historic and Forecasted Market Size By Application
13.5.1 Cancers
13.5.2 Inherited Disorders
13.5.3 Viral Infections
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Viral Vectors and Plasmid DNA Manufacturing Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Plasmid DNA
14.4.2 Viral Vectors
14.5 Historic and Forecasted Market Size By Application
14.5.1 Cancers
14.5.2 Inherited Disorders
14.5.3 Viral Infections
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Viral Vectors and Plasmid DNA Manufacturing Scope:
|
Report Data
|
Viral Vectors and Plasmid DNA Manufacturing Market
|
|
Viral Vectors and Plasmid DNA Manufacturing Market Size in 2022
|
USD 719.33 million
|
|
Viral Vectors and Plasmid DNA Manufacturing CAGR 2023 - 2030
|
18.18%
|
|
Viral Vectors and Plasmid DNA Manufacturing Base Year
|
2022
|
|
Viral Vectors and Plasmid DNA Manufacturing Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory.
|
|
Key Segments
|
By Type
Plasmid DNA
Viral Vectors
By Applications
Cancers
Inherited Disorders
Viral Infections
Others
|
